Drug safety is evaluated through preclinical and clinical testing phases. Preclinical studies involve in vitro (test tube) and in vivo (animal) experiments to assess potential toxicity. Clinical trials in humans are conducted in multiple phases to monitor safety, efficacy, and side effects. Regulatory agencies such as the FDA and EMA require thorough safety data before granting approval for public use.
